Groundbreaking Ozempic Study Could Increase Access for People with Chronic Kidney Disease
AdventHealth researcher, Dr. Richard E. Pratley, is the senior author on this recently published New England Journal of Medicine paper,...
AdventHealth researcher, Dr. Richard E. Pratley, is the senior author on this recently published New England Journal of Medicine paper,...
The trial encompassed all 26 renal care facilities in Ontario dedicated to advanced treatment of chronic kidney disease. (YuriArcursPeopleimages/Envato Elements) By...